MN576 Unit 5 exam with correct answers
| | | | | |
In |assessing |a |woman |with |disabilities, |which |of |the |following |terms |should |be |avoided?
Question |1 |options:
1) |Crippled
2) |Handicapped
3) |Mentally |retarded
4) |All |of |the |above |- |correct |answer |4) |All |of |the |above
Which |of |the |following |terms |describes |the |mechanism |of |action |of |imiquimod |(Aldara)?
Question |2 |options:
1) |keratolytic
2) |immune |modulator
3) |cryogenic |
4) |cytolytic |- |correct |answer |2) |immune |modulator
The |NP |is |seeing |a |30-year-old |woman |before |her |routine |gynecologic |examination, |the |NP |
questions |that |patient |about
her |recent |menstrual |cycles. |Which |statement |made |by |the |patient |should |prompt |further |
investigation?
Question |3 |options:
,1) |"My |flow |is |very |heavy |all |the |time."
2) |"I |have |occasionally |spot |in |between |cycles"
3) |"My |menstrual |cycles |varies |from |25 |to |30 |days."
4) |"I |have |cramping |prior |to |my |cycle |starting" |- |correct |answer |1) |"My |flow |is |very |heavy |all |
the |time."
Complementary |and |alternative |medicine |(CAM) |is |defined |as |a |group |of |therapies |that |are |
not |considered |part |of |Western |culture |and |include |all |of |the |following |except:
Question |4 |options:
1) |Congugated |estrogen
2) |Aromatherapy
3) |Tai |Chi
4) |Yoga |- |correct |answer |1) |Congugated |estrogen
Which |HPV |types |are |most |often |associated |with |cervical |and |anogenital |cancer?
1) |1, |2, |and |3
2) |6 |and |11
3) |16 |and |18
4) |22 |and |24 |- |correct |answer |3) |16 |and |18
When |counseling |a |woman |about |COC |use, |you |advise |that: |Question |6 |options:
1) |long-term |use |of |COC |is |discouraged |because |the |body |needs |a |"rest" |from |birth |control |
pills |from |time |to |time.
2) |fertility |is |often |delayed |for |many |months |after |discontinuation |of |COC.
3) |there |is |an |increase |in |the |rate |of |breast |cancer |after |protracted |use |of |COC.
, 4) |premenstrual |syndrome |symptoms |are |often |improved |with |use |of |COC. |- |correct |answer |4)
|premenstrual |syndrome |symptoms |are |often |improved |with |use |of |COC.
Puberty |consists |of |a |series |of |predictable |events, |and |the |sequence |of |changes |in |secondary |
sexual |characteristics |has |been |categorized |by |several |groups. |The |staging |system |utilized |most
|frequently |used |to |describe |these |events |is |Tanner |staging.
1) |True |
2) |False |- |correct |answer |1) |True
A |preferred |treatment |option |for |trichomoniasis |is:
1) |oral |metronidazole |
2) |clindamycin |vaginal |cream
3) |topical |acyclovir.
4) |oral |azithromycin. |- |correct |answer |1) |oral |metronidazole
Which |of |the |following |agents |is |active |against |N. |gonorrhoeae? |Question |options:
1) |ceftriaxone
2) |metronidazole |
3) |ketoconazole |
4) |amoxicillin |- |correct |answer |1) |ceftriaxone
A |recommended |treatment |for |rectal |gonorrhea |is: |Question |options:
1) |oral |amoxicillin.
| | | | | |
In |assessing |a |woman |with |disabilities, |which |of |the |following |terms |should |be |avoided?
Question |1 |options:
1) |Crippled
2) |Handicapped
3) |Mentally |retarded
4) |All |of |the |above |- |correct |answer |4) |All |of |the |above
Which |of |the |following |terms |describes |the |mechanism |of |action |of |imiquimod |(Aldara)?
Question |2 |options:
1) |keratolytic
2) |immune |modulator
3) |cryogenic |
4) |cytolytic |- |correct |answer |2) |immune |modulator
The |NP |is |seeing |a |30-year-old |woman |before |her |routine |gynecologic |examination, |the |NP |
questions |that |patient |about
her |recent |menstrual |cycles. |Which |statement |made |by |the |patient |should |prompt |further |
investigation?
Question |3 |options:
,1) |"My |flow |is |very |heavy |all |the |time."
2) |"I |have |occasionally |spot |in |between |cycles"
3) |"My |menstrual |cycles |varies |from |25 |to |30 |days."
4) |"I |have |cramping |prior |to |my |cycle |starting" |- |correct |answer |1) |"My |flow |is |very |heavy |all |
the |time."
Complementary |and |alternative |medicine |(CAM) |is |defined |as |a |group |of |therapies |that |are |
not |considered |part |of |Western |culture |and |include |all |of |the |following |except:
Question |4 |options:
1) |Congugated |estrogen
2) |Aromatherapy
3) |Tai |Chi
4) |Yoga |- |correct |answer |1) |Congugated |estrogen
Which |HPV |types |are |most |often |associated |with |cervical |and |anogenital |cancer?
1) |1, |2, |and |3
2) |6 |and |11
3) |16 |and |18
4) |22 |and |24 |- |correct |answer |3) |16 |and |18
When |counseling |a |woman |about |COC |use, |you |advise |that: |Question |6 |options:
1) |long-term |use |of |COC |is |discouraged |because |the |body |needs |a |"rest" |from |birth |control |
pills |from |time |to |time.
2) |fertility |is |often |delayed |for |many |months |after |discontinuation |of |COC.
3) |there |is |an |increase |in |the |rate |of |breast |cancer |after |protracted |use |of |COC.
, 4) |premenstrual |syndrome |symptoms |are |often |improved |with |use |of |COC. |- |correct |answer |4)
|premenstrual |syndrome |symptoms |are |often |improved |with |use |of |COC.
Puberty |consists |of |a |series |of |predictable |events, |and |the |sequence |of |changes |in |secondary |
sexual |characteristics |has |been |categorized |by |several |groups. |The |staging |system |utilized |most
|frequently |used |to |describe |these |events |is |Tanner |staging.
1) |True |
2) |False |- |correct |answer |1) |True
A |preferred |treatment |option |for |trichomoniasis |is:
1) |oral |metronidazole |
2) |clindamycin |vaginal |cream
3) |topical |acyclovir.
4) |oral |azithromycin. |- |correct |answer |1) |oral |metronidazole
Which |of |the |following |agents |is |active |against |N. |gonorrhoeae? |Question |options:
1) |ceftriaxone
2) |metronidazole |
3) |ketoconazole |
4) |amoxicillin |- |correct |answer |1) |ceftriaxone
A |recommended |treatment |for |rectal |gonorrhea |is: |Question |options:
1) |oral |amoxicillin.
